AstraZeneca Pharma India Receives ESG Score of 64.4 (Grade B)

AstraZeneca Pharma India Limited has received an Environmental, Social, and Governance (ESG) Report, with an ESG Score (Adjusted) of 64.4 (Grade B). The score was assigned on January 30, 2026, based on publicly available information pertaining to Financial Year 2024-25. The company clarifies it did not engage SES for this ESG Rating, and the report was independently prepared.

ESG Rating Details

AstraZeneca Pharma India Limited has received an ESG score of 64.4 (Grade B), based on an Environmental, Social, and Governance (ESG) Report. This report was received on January 30, 2026.

Basis of the Rating

The ESG score is based on publicly available information related to the financial year 2024-25. The report was prepared by SES ESG Research Private Limited.

Company Clarification

AstraZeneca Pharma India Limited clarifies that it did not engage SES for this ESG Rating. SES independently prepared the report using publicly accessible information.

Source: BSE

Previous Article

Sundaram Finance Q3 FY26 Results - PAT at ₹402.87 Crore

Next Article

eMudhra Board Approves Key Leadership Appointments and Re-appointments